Holen Sie sich die Stockscreener-App
14.14
0.04%
0.00
Schlusskurs vom Vortag:
$14.14
Offen:
$14.15
24-Stunden-Volumen:
59,452
Relative Volume:
0.44
Marktkapitalisierung:
$166.70M
Einnahmen:
$42.16M
Nettoeinkommen (Verlust:
$-14.38M
KGV:
-7.8994
EPS:
-1.79
Netto-Cashflow:
$-9.90M
1W Leistung:
-4.55%
1M Leistung:
+8.81%
6M Leistung:
+218.58%
1J Leistung:
+316.40%
1-Tages-Spanne:
$14.14
$14.20
1-Wochen-Bereich:
$14.06
$14.58
52-Wochen-Spanne:
$2.67
$17.31
Lensar Inc Stock (LNSR) Company Profile
Firmenname
Lensar Inc
Sektor
Branche
Telefon
888-536-7271
Adresse
2800 DISCOVERY DRIVE, ORLANDO
Vergleichen Sie LNSR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
14.14 | 166.70M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
131.39 | 229.15B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.10 | 145.39B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
365.43 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.40 | 112.64B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.78 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-02-24 | Eingeleitet | SVB Leerink | Outperform |
Lensar Inc Aktie (LNSR) Neueste Nachrichten
Alcon Inc’s Acquisition of LENSAR Inc - Global Legal Chronicle
Related Content: Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics.com
Alcon to buy Lensar in deal worth up to $430M - The Business Journals
Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics.com
ALC Stock Rises Following the Merger Agreement With LENSAR - MSN
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc.LNSR - Business Wire
Alcon lines up Lensar deal to expand laser cataract surgery options - Optics.org
Alcon signs merger agreement to acquire Lensar - Yahoo
BTIG Research Downgrades LENSAR to Neutral From Buy - Marketscreener.com
Alcon agrees to purchase LENSAR - Ophthalmology Times
Switzerland: Alcon agrees acquisition of Lensar for up to US$430m - Investors in Healthcare
LENSAR’s (LNSR) “Hold” Rating Reaffirmed at Lake Street Capital - Defense World
Alcon Agrees to Acquire Lensar, Inc. for Up to $430 Million - Vision Monday
BTIG cuts LENSAR stock rating post Alcon acquisition deal - Investing.com India
BTIG cuts LENSAR stock rating post Alcon acquisition deal By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc.LNSR - The Malaysian Reserve
Latham & Watkins Represents LENSAR, Inc. in Acquisition by Alcon - Latham & Watkins LLP
Alcon to Acquire LENSAR in $430M Deal - USA Herald
Alcon to acquire Lensar for up to $430M - BioWorld Online
Norton Rose, Latham Steer Alcon's $430M Lensar Buy - Law360
Alcon agrees to acquire LENSAR for $14.00 per share - MSN
Alcon to acquire LENSAR for up to $430 million By Investing.com - Investing.com South Africa
Alcon to Acquire Lensar for up to $430 million. - MD+DI
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of LENSAR, Inc. (LNSR) - TradingView
Alcon Agrees to Acquire LENSAR, Inc. - Sharewise
Lake Street Downgrades LENSAR to Hold From Buy, Price Target is $15 -March 24, 2025 at 11:54 am EDT - Marketscreener.com
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - Benzinga
Switzerland's Alcon to Buy US-based Medical Technology Group Lensar -March 24, 2025 at 09:48 am EDT - Marketscreener.com
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire
LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders - Bluefield Daily Telegraph
Alcon to Buy Lensar for up to $430 Million - MPO-mag
Alcon to Acquire Lensar for $430 Million -March 24, 2025 at 08:42 am EDT - Marketscreener.com
Alcon to acquire LENSAR for up to $430 million - Investing.com
LENSAR Announces Merger Agreement with Alcon - TipRanks
Alcon Agrees To Acquire LENSAR For Up To Approximately $430 Mln - Nasdaq
Alcon Agrees To Acquire Lensar, Inc. -March 24, 2025 at 08:03 am EDT - Marketscreener.com
Major Medical Tech Deal: Alcon Buys LENSAR at 47% Premium, Eyes $32B Cataract Market - StockTitan
LENSAR, Inc. (NASDAQ:LNSR) Shares Purchased by Atria Investments Inc - Defense World
LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU - Business Wire
LENSARTop Healthcare Equipment Stock - Inkl
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
LENSAR announces inducement grants - Medical Buyer
Lensar Inc. Reports Record Revenue and Optimistic Outlook - TipRanks
LENSAR Awards New Hires Stock Options at $13.48What This Means for Shareholders - StockTitan
LENSAR, Inc. (NASDAQ:LNSR) Q4 2024 Earnings Call Transcript - Insider Monkey
LENSAR (NASDAQ:LNSR) Price Target Raised to $16.00 - Defense World
LENSAR revenue jumps 38% to USD 16.7M in Q4 2024 - Medical Buyer
LENSAR (NASDAQ:LNSR) Announces Quarterly Earnings Results - MarketBeat
LENSAR Inc (LNSR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Yahoo Finance
LENSAR, Inc. Reports Strong 2024 Financial Performance - TipRanks
LENSAR, Inc. SEC 10-K Report - TradingView
Finanzdaten der Lensar Inc-Aktie (LNSR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lensar Inc-Aktie (LNSR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Winer Gary M | Director |
Aug 28 '24 |
Buy |
4.45 |
1,000 |
4,450 |
80,155 |
| Winer Gary M | Director |
Aug 26 '24 |
Buy |
4.58 |
802 |
3,673 |
78,655 |
| Winer Gary M | Director |
Aug 27 '24 |
Buy |
4.50 |
500 |
2,250 |
79,155 |
| Winer Gary M | Director |
Aug 21 '24 |
Buy |
4.35 |
500 |
2,176 |
77,851 |
| Winer Gary M | Director |
Aug 22 '24 |
Buy |
4.30 |
2 |
9 |
77,853 |
| Winer Gary M | Director |
Aug 20 '24 |
Buy |
4.20 |
500 |
2,100 |
77,351 |
| Winer Gary M | Director |
Aug 16 '24 |
Buy |
4.03 |
6 |
24 |
76,851 |
| Winer Gary M | Director |
Aug 14 '24 |
Buy |
4.20 |
1,000 |
4,200 |
76,845 |
| Winer Gary M | Director |
Aug 12 '24 |
Buy |
4.03 |
500 |
2,015 |
75,845 |
| STAAB THOMAS R II | Chief Financial Officer |
Aug 08 '24 |
Option Exercise |
2.65 |
3,500 |
9,275 |
162,434 |
0.94%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):